- Home
- EIX vs ILMN Comparison
EIX vs ILMN Comparison
Compare EIX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIX
- ILMN
- Stock Information
- Founded
- EIX 1886
- ILMN 1998
- Country
- EIX United States
- ILMN United States
- Employees
- EIX N/A
- ILMN N/A
- Industry
- EIX Electric Utilities: Central
- ILMN Medical Specialities
- Sector
- EIX Utilities
- ILMN Health Care
- Exchange
- EIX Nasdaq
- ILMN Nasdaq
- Market Cap
- EIX 21.3B
- ILMN 18.4B
- IPO Year
- EIX N/A
- ILMN 2000
- Fundamental
- Price
- EIX $58.42
- ILMN $121.74
- Analyst Decision
- EIX Hold
- ILMN Hold
- Analyst Count
- EIX 12
- ILMN 15
- Target Price
- EIX $65.27
- ILMN $114.93
- AVG Volume (30 Days)
- EIX 2.8M
- ILMN 1.9M
- Earning Date
- EIX 10-28-2025
- ILMN 10-30-2025
- Dividend Yield
- EIX 5.67%
- ILMN N/A
- EPS Growth
- EIX 123.49
- ILMN N/A
- EPS
- EIX 7.64
- ILMN 4.46
- Revenue
- EIX $18,088,000,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- EIX $7.30
- ILMN N/A
- Revenue Next Year
- EIX $2.70
- ILMN $2.22
- P/E Ratio
- EIX $7.65
- ILMN $27.34
- Revenue Growth
- EIX 4.43
- ILMN N/A
- 52 Week Low
- EIX $47.73
- ILMN $68.70
- 52 Week High
- EIX $88.65
- ILMN $153.06
- Technical
- Relative Strength Index (RSI)
- EIX 59.24
- ILMN 64.64
- Support Level
- EIX $56.86
- ILMN $117.10
- Resistance Level
- EIX $59.34
- ILMN $122.79
- Average True Range (ATR)
- EIX 1.13
- ILMN 5.53
- MACD
- EIX 0.16
- ILMN 0.21
- Stochastic Oscillator
- EIX 84.60
- ILMN 86.86
About EIX Edison International
Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.